Likang Life Sciences
PrivateLast Round
Corporate Funding
Jun 26, 2026
Est. Valuation
$137.4M
Total Funding Raised
$27.42M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Likang Life Sciences is a biotechnology company that develops personalized immune cell therapies and mRNA-based tumor neoantigen vaccines for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Likang Life Sciences Comparables
Compare Likang Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Siwei Biotechnology | 86% | |
| NeoCura Bio-Medical Technology Co., Ltd. | 85% | |
| Anda Biopharma | 83% |
Likang Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 26, 2026 | ||||
| Strategic | Feb 24, 2025 | ||||
| Angel | Sep 21, 2023 |
Likang Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing E-Town International Investment & Development Co., Ltd. | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 86% MoM, reaching 1.4K.
- Jun 26, 2026
$16.1M raised in corporate funding.
Recent news
Latest coverage and updates
- expands_facilitiesAug 21, 2026
Likang Life expanded facilities to Beijing, China, Eastern Asia, Asia on Jun 1st '26.
- invests_into_assetsAug 21, 2026
Likang Life invested into assets: drug R&D and manufacturing center in the amount of $16.4M in Beijing, China, Eastern Asia, Asia on Jun 1st '26.
Likang Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Likang Life Sciences's valuation, stock price, and market status.
Is Likang Life Sciences a public or private company?
Likang Life Sciences is a private company.
What is the current stock price of Likang Life Sciences?
Likang Life Sciences is a private company with no public stock price. No recent secondary market data is available.
How much is Likang Life Sciences worth (valuation)?
Likang Life Sciences's valuation is estimated at $137.4M based on funding round data.
Can I buy Likang Life Sciences stock?
Likang Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Likang Life Sciences's last funding round?
Likang Life Sciences's most recent funding round was Corporate Funding on September 21, 2023.
Who are the main investors in Likang Life Sciences?
Key investors in Likang Life Sciences include Beijing E-Town International Investment & Development Co., Ltd..
Will Likang Life Sciences IPO soon?
No public IPO plans have been announced for Likang Life Sciences.
How can I track Likang Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Likang Life Sciences's secondary market activity and sign up for updates.